Hemostasis

How can the answer be improved? VWD Profile . If the APTT is prolonged and the factor VIII is normal, this panel reflexes to an APTT Reflexive Evaluation Profile . APTT Reflexive Evaluation Profile HEMOSTASIS REFERENCE LABORATORY (206) 689-6594 SAMPLE COLLECTION REQUIREMENTS All coagulation testing is done using platelet-poor plasma from 3.2% sodium citrate collection tubes. Send two 5 ml or three 3 ml sodium citrate whole blood tubes .

HyperBranch Medical Technology

The MedTech landscape is shifting, with challenges in the form of ever-changing ... How can the answer be improved? Company profile page for HyperBranch Medical Technology Inc including stock price, company news, press releases, executives, board members, and contact information

InnoTherapy

Jul 25, 2019 · InnoTherapy , Inc., a medical device company, develops hemostatic adhesives that treat bleeding situations and various surgical environments. Sep 20, 2010 · Brief Historical Overview of InnoTherapy 2010. 4 InnoTherapy Inc. found 2010. 6 Technology Transfer Agreement from KAIST 2010. 6 Venture Company approval from Korea government 2010. 8 SEG Technology Development 2010. 9 BIOKOREA2010 presentation Vision 1. Competitive Platform Technology (SEG etc.) 2. Profitable & Integrated New Business Model ... InnoTherapy , Inc. is engaged in the manufacturing of pharmaceutical products. It operates through following businesses: Absorbable Hemostat and Surgical Sealant. Its products include Hemoleast, InnoSEAL, Hemo Powder, Liquid Stent, Medical Adhesive, and Surgical Sealant.

Marine Polymer Technologies

Marine Polymer Technologies , Inc. (MPT) is an innovative medical device company focused on the development and delivery of biomaterials for the medical field. Since 1992, weve introduced ground-breaking products in the areas of wound healing, hemostasis and the control of severe bleeding to support healthcare providers and their patients. Glassdoor gives you an inside look at what its like to work at Marine Polymer Technologies , including salaries, reviews, office photos, and more. This is the Marine Polymer Technologies company profile . All content is posted anonymously by employees working at Marine Polymer Technologies . Company profile page for Marine Polymer Technologies Inc including stock price, company news, press releases, executives, board members, and contact information.

MedTrade Products

Company profile page for Medtrade Products Ltd including stock price, company news, press releases, executives, board members, and contact information. Information on valuation, funding, acquisitions, investors, and executives for MedTrade Products . Use the PitchBook Platform to explore the full profile . The intellectual property of MedTrade Products Ltd includes 17 registered patents primarily in the Medical Or Veterinary Science; Hygiene category. Additionally, MedTrade Products Ltd has registered 12 trademarks with the most popular class being Pharmaceutical, veterinary and sanitary products .

Meyer-Haake

Jul 26, 2019 · For the Meyer-Haake Academy we have been able to obtain high profile experts, and offer a tailor made range of seminars and lectures under the motto: Success through competence and expertise. Due to the extensive program diversity, courses for all fields are available. Company Profile It its almost 30 years of existence, the Meyer-Haake company has developed from an importer of American dental products into a manufacturer of an independent dental and medical line of products. 1981 Founding of the company in Marl, Germany. 1982 Take-over by Mrs. Christine Meyer-Haake and transfer to Frankfurt / Main. Profile : The Meyer-Haake company was founded in 1981 by Ms. Meyer-Haake with a product line for dentistry. In 1989 the first high frequency surgical unit was placed on the market, which was followed by a second version in 1992. In spring 2003 Meyer-Haake

Ocular Therapeutix

Jul 30, 2019 · Company Description. Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on Sep... Description. Ocular Therapeutix , Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. Its lead product candidates include DEXTENZA (dexamethasone insert) for the treatment of post-surgical ocular pain ... Full Description. Ocular Therapeutix , Inc., incorporated on September 12, 2006, is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert)...

OptMed

OptMed . The companys biocompatible polymer and genitourinary therapeutic platform offers investigation devices that combines proprietary polymer and advanced delivery technology, enabling doctors to treat lower urinary tract conditions, including overactive bladder and kidney stones. You’re viewing a free company profile ... Jul 23, 2019 · Company Overview. OptMed , Inc. develops and sells specialty healthcare products worldwide. The company offers surgical and biocompatible adhesives; BondEase, a topical skin adhesive; bio surgical adhesives for use in emergency and operating rooms, and dermatology settings; and internal sealants for vascular and gastrointestinal anastomoses... Company profile page for OptMed Inc including stock price, company news, press releases, executives, board members, and contact information

For More information, Please access Read the total report.